Liuzzo, Giovanna
 Distribuzione geografica
Continente #
EU - Europa 4.937
NA - Nord America 4.299
AS - Asia 1.890
SA - Sud America 361
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 10
Totale 11.549
Nazione #
US - Stati Uniti d'America 4.247
DE - Germania 2.015
CN - Cina 774
SE - Svezia 771
IT - Italia 688
SG - Singapore 636
UA - Ucraina 330
BR - Brasile 325
FR - Francia 310
IE - Irlanda 200
GB - Regno Unito 169
FI - Finlandia 133
ID - Indonesia 128
RU - Federazione Russa 96
IN - India 87
TR - Turchia 62
AT - Austria 44
CA - Canada 37
BE - Belgio 34
HK - Hong Kong 32
KR - Corea 31
PL - Polonia 30
NL - Olanda 26
IR - Iran 24
CI - Costa d'Avorio 18
CZ - Repubblica Ceca 16
LT - Lituania 16
VN - Vietnam 15
AR - Argentina 14
JP - Giappone 13
CH - Svizzera 11
CL - Cile 10
MX - Messico 10
AU - Australia 9
ES - Italia 9
TW - Taiwan 9
BD - Bangladesh 8
UZ - Uzbekistan 8
IL - Israele 7
IQ - Iraq 7
PT - Portogallo 7
ZA - Sudafrica 7
RO - Romania 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
EU - Europa 5
LK - Sri Lanka 5
VE - Venezuela 5
A2 - ???statistics.table.value.countryCode.A2??? 4
LV - Lettonia 4
CY - Cipro 3
DZ - Algeria 3
EC - Ecuador 3
EE - Estonia 3
GE - Georgia 3
GR - Grecia 3
KG - Kirghizistan 3
MA - Marocco 3
OM - Oman 3
PK - Pakistan 3
A1 - Anonimo 2
AM - Armenia 2
CO - Colombia 2
EG - Egitto 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
AL - Albania 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
LB - Libano 1
LI - Liechtenstein 1
MT - Malta 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
SC - Seychelles 1
SD - Sudan 1
SI - Slovenia 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 11.549
Città #
Chandler 882
Singapore 444
Ashburn 339
New York 258
Jacksonville 220
Dublin 199
San Mateo 190
Nanjing 184
Rome 173
Milan 162
Jakarta 127
Wilmington 107
Nürnberg 106
Marseille 99
Ann Arbor 87
Boston 87
Cattolica 86
Dearborn 84
Los Angeles 73
Woodbridge 72
Houston 71
Nanchang 70
Moscow 69
Bremen 67
Munich 61
Lawrence 53
The Dalles 53
Helsinki 50
Redwood City 48
North Bergen 45
Seattle 44
Izmir 42
Princeton 42
Frankfurt am Main 40
Düsseldorf 37
Fairfield 36
Brussels 34
Hefei 34
Chicago 33
Leawood 33
London 31
Boardman 28
Seoul 28
Tianjin 28
Vienna 28
Hangzhou 27
Kunming 27
Zhengzhou 27
Hong Kong 25
Fremont 24
Mountain View 23
Nuremberg 23
Pune 22
Shenyang 22
Beijing 21
Detroit 20
Hebei 20
University Park 20
Changsha 19
Abidjan 18
Lauterbourg 18
São Paulo 17
Gmina Zabierzów 15
Guangzhou 15
Hyderabad 15
Jiaxing 15
Andover 14
Washington 14
Rio de Janeiro 13
San Francisco 13
Toronto 13
Enterprise 12
Lancaster 12
Saint Louis 12
Shanghai 12
Turku 12
Augusta 11
Belo Horizonte 11
Falls Church 11
Kish 11
Redmond 11
Roubaix 11
Cambridge 9
Changchun 9
Montreal 9
Norwalk 9
Ottawa 9
Jinan 8
Kaohsiung City 8
Amsterdam 7
Bielefeld 7
Brooklyn 7
Busto Arsizio 7
Campinas 7
Costa Mesa 7
Falkenstein 7
Ho Chi Minh City 7
Lappeenranta 7
Porto Alegre 7
Santa Clara 7
Totale 5.848
Nome #
Paradoxical preservation of vascular function in severe obesity 289
Adaptive immunity, inflammation, and cardiovascular complications in type 1 and type 2 diabetes mellitus 237
Different apparent prognostic value of hsCRP in type 2 diabetic and nondiabetic patients with acute coronary syndromes 208
CD4+CD28null T lymphocytes are expanded in young women with polycystic ovary syndrome 199
Predictors of Postoperative Atrial Fibrillation in Patients with Coronary Artery Disease Undergoing Cardiopulmonary Bypass: A Possible Role for Myocardial Ischemia and Atrial Inflammation 185
Effects of bariatric surgery on cardiac remodeling: clinical and pathophysiologic implications 170
Delayed neutrophil apoptosis in patients with unstable angina: relation to C-reactive protein and recurrence of instability 168
Predictors of postoperative atrial fibrillation in patients with coronary artery disease undergoing cardiopulmonary bypass: a possible role for myocardial ischemia and atrial inflammation 160
Altered CD31 expression and activity in helper T cells of acute coronary syndrome patients 152
Endothelial progenitor cells in morbid obesity 152
GLUT-1/PKM2 loop dysregulation in patients with non-ST-segment elevation myocardial infarction promotes metainflammation 149
Cardiovascular risk in obesity: different activation of inflammation and immune system between obese and morbidly obese subjects 148
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 144
N-Acetylcysteine and High-Dose Atorvastatin Reduce Oxidative Stress in an Ischemia-Reperfusion Model in the Rat Kidney 144
CD4(+)CD28(null) T lymphocyte frequency, a new marker of cardiovascular risk: relationship with polycystic ovary syndrome phenotypes 143
High telomerase activity in neutrophils from unstable coronary plaques 143
Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study). 142
Thromboxane production in morbidly obese subjects 141
Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-γ in patients with chronic heart failure. 137
Reduced CD31 expression on CD14(+)CD16(+) monocyte subset in acute coronary syndromes 137
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 136
COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment 134
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus 133
Air Pollution and Coronary Plaque Vulnerability and Instability: An Optical Coherence Tomography Study 133
Chlamydia pneumoniae in coronary atherosclerotic plaques and coronary instability 130
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function 129
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). 128
Pioglitazone reduces monocyte activation in type 2 diabetes 128
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus 124
Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients 123
Increased PTPN22 Expression and Defective CREB Activation Impair Regulatory T-Cell Differentiation in Non-ST-Segment Elevation Acute Coronary Syndromes 122
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 121
Clinical, angiographic and echocardiographic correlates of epicardial and microvascular spasm in patients with myocardial ischaemia and non-obstructive coronary arteries 121
Chlamydia pneumoniae in coronary atherosclerotic plaques and coronary instability 120
HIGH-DOSE ATORVASTATIN REDUCE OXIDATIVE STRESS OF ISCHEMIA/REPERFUSION INJURY AFTER ISOGENEIC KIDNEY TRANSPLANTATION IN RATS 120
Parvovirus B19 at the culprit coronary stenosis predicts outcome after stenting 117
Infections, immunity and atherosclerosis: pathogenic mechanisms and unsolved questions 117
Identification of unique adaptive immune system signature in acute coronary syndromes 116
Role of tissue C-reactive protein in atrial cardiomyocytes of patients undergoing catheter ablation of atrial fibrillation: Pathogenetic implications 113
Atorvastatin inhibits the immediate-early response gene EGR1 and improves the functional profile of CD4+T-lymphocytes in acute coronary syndromes 113
Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus 112
Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus 112
Predictors of periprocedural (type IVa) myocardial infarction, as assessed by frequency-domain optical coherence tomography 109
Correlation between CD4 + CD28 null T lymphocytes, regulatory T cells and plaque rupture: An Optical Coherence Tomography study in Acute Coronary Syndromes 107
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial. 105
Inflammasome, T Lymphocytes and Innate-Adaptive Immunity Crosstalk: Role in Cardiovascular Disease and Therapeutic Perspectives 105
Alterations of Hyaluronan Metabolism in Acute Coronary Syndrome: Implications for Plaque Erosion 105
Matrix metalloproteinase-9 might affect adaptive immunity in non-ST segment elevation acute coronary syndromes by increasing CD31 cleavage on CD4+ T-cells 105
Advances in mechanisms, imaging and management of the unstable plaque 104
Indoleamine 2,3-dioxygenase (IDO) enzyme links innate immunity and altered T-cell differentiation in Non-ST segment elevation acute coronary syndrome 104
Effect of Remote Ischemic Preconditioning on Platelet Activation Induced by Coronary Procedures 102
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial 100
Epicardial adipose tissue microbial colonization and inflammasome activation in acute coronary syndrome 100
Predicting the no-reflow phenomenon following successful percutaneous coronary intervention 97
Infarct-related artery occlusion, tissue markers of ischemia, and increased apoptosis in the peri-infarct viable myocardium. 97
Vaccines and Myocardial Injury in Patients Hospitalized for COVID-19 Infection: the CardioCOVID-Gemelli Study 95
Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention 92
Identification of unique adaptive immune system signature in acute coronary syndromes 92
Allergic Inflammation Is Associated With Coronary Instability and a Worse Clinical Outcome After Acute Myocardial Infarction 89
The cardiovascular relevance of celiac disease 87
Response to Letter Regarding Article, "Allergic Inflammation Is Associated With Coronary Instability and a Worse Clinical Outcome After Acute Myocardial Infarction" 87
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 85
Role of perilipin 2 in microvascular obstruction in patients with ST-elevation myocardial infarction 82
Personalized Clinical Phenotyping through Systems Medicine and Artificial Intelligence 79
Adaptive Immunity Dysregulation in Acute Coronary Syndromes: From Cellular and Molecular Basis to Clinical Implications 78
Platelet hyaluronidase 2 enrichment in acute coronary syndromes: a conceivable role in monocyte-platelet aggregate formation 77
Brain-derived neurotrophic factor in patients with acute coronary syndrome 76
From angiotensin-converting enzyme 2 disruption to thromboinflammatory microvascular disease: A paradigm drawn from COVID-19 75
Perilipin 2 levels are increased in patients with in-stent neoatherosclerosis: A clue to mechanisms of accelerated plaque formation after drug-eluting stent implantation 74
A Novel Monocyte Subset as a Unique Signature of Atherosclerotic Plaque Rupture 74
Monocyte-Platelet Aggregates Triggered by CD31 Molecule in Non-ST Elevation Myocardial Infarction: Clinical Implications in Plaque Rupture 74
Coronary slow flow is associated with a worse clinical outcome in patients with Takotsubo syndrome 73
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial 72
Clinical Impact of Heart Team Decisions for Patients With Complex Valvular Heart Disease: A Large, Single-Center Experience 71
Interleukin-17 in atherosclerosis and cardiovascular disease: the good, the bad, and the unknown 70
Between Death and Hope After Out-of-Hospital Cardiac Arrest: Should We Rely on Biomarkers? 70
Not all plaque ruptures are born equal: An optical coherence tomography study 70
Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention 69
Personalized clinical phenotyping through systems medicine and artificial intelligence 69
Where Does Inflammation Fit? 68
Molecular Hallmarks of Ischemia with Non-Obstructive Coronary Arteries: The “INOCA versus Obstructive CCS” Challenge 68
Endothelial and smooth muscle cells dysfunction distal to recanalized chronic total coronary occlusions and the relationship with the collateral connection grade 65
Interleukin-17 in atherosclerosis and cardiovascular disease: the good, the bad, and the unknown 64
Use of Levosimendan as bridge therapy to surgical correction of post-infarction ventricular septal defect: a case report 64
Colchicine in ischemic heart disease: the good, the bad and the ugly 64
Microvascular complications identify a specific coronary atherosclerotic phenotype in patients with type 2 diabetes mellitus 63
Brain-derived neurotrophic factor in patients with acute coronary syndrome 62
Role of perilipin 2 in microvascular obstruction in patients with ST-elevation myocardial infarction 62
Pathogenesis of acute coronary syndromes 61
Precision medicine versus standard of care for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA): rationale and design of the multicentre, randomised PROMISE trial 60
Restricted T-Cell Repertoire in the Epicardial Adipose Tissue of Non-ST Segment Elevation Myocardial Infarction Patients 59
Anti-inflammatory treatment of acute coronary syndromes: The need for precision medicine 59
Upregulated monocyte expression of PLIN2 is associated with early arterial injury in children with overweight/obesity 59
Air pollution and plaque healing in acute coronary syndromes 58
Addressing Acute Coronary Syndromes: New Challenges and Opportunities After the CANTOS Trial (Canakinumab Anti-inflammatory Thrombosis Outcomes Study) 58
Incidence and predictors of thrombotic complications in 4742 patients with COVID-19 or other acute infectious respiratory diseases: A propensity score-matched study 58
Device-based remote monitoring strategies for congestion-guided management of patients with heart failure: a systematic review and meta-analysis 57
Impact of air pollution on ischemic heart disease: Evidence, mechanisms, clinical perspectives 57
High-dose atorvastatin reduces oxidative stress of ischemia/reperfusion injury after isogeneic kidney transplantation in rats: in vivo, preclinical, case–control, open-label study 56
[Tryptase levels are elevated during spontaneous ischemic episodes in unstable angina but not after the ergonovine test in variant angina]. 55
Totale 10.547
Categoria #
all - tutte 50.401
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.401


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202085 0 0 0 0 0 0 0 0 0 0 0 85
2020/2021684 20 67 10 68 87 48 86 27 95 20 131 25
2021/20221.165 49 73 21 46 55 60 27 197 46 118 239 234
2022/20232.503 328 340 221 399 127 285 157 193 276 72 54 51
2023/20241.434 44 312 57 72 59 330 77 66 35 63 151 168
2024/20252.495 67 99 237 108 238 83 102 121 445 315 646 34
Totale 11.722